Dr Susan Wyllie

Dr Susan Wyllie has more than 15 years of experience studying kinetoplastid biology. Specifically, her research has focused on determining the mechanisms of action and mechanisms of resistance of drugs targeting kinetoplastid parasites. Her contributions to the research of the Wellcome Centre for Anti-Infectives Research will include:

Using complementary methodologies in the fields of genomics, chemical proteomics and cell biology to determine the modes of action and specific molecular targets of phenotypically-active compounds

Developing new genetic and cell biology tools for the study of drug mechanism of action

Functional characterisation of novel targets

Developing novel cell-based assays to exploit high value drug targets